Nov 09, 2020 / Presentations Improving competition among Part D’s benchmark plans Research Areas: Drugs, Devices, and Tests, Private Plans
Nov 09, 2020 / Presentations Effects of pharmaceutical manufacturer rebates on Part D’s risk adjustment Research Areas: Drugs, Devices, and Tests, Private Plans
Oct 30, 2020 / Meeting Brief Congressional request: Medicare beneficiaries’ access to care in rural areas (interim report)
Oct 30, 2020 / Meeting Brief Separately payable drugs in the hospital outpatient prospective payment system
Oct 30, 2020 / Meeting Brief Medicare Advantage payment and access for enrollees with end-stage renal disease
Oct 30, 2020 / Meeting Brief Effects of pharmaceutical manufacturer rebates on Part D’s risk adjustment
Oct 29, 2020 / Comment Letters MedPAC comment on CMS’s proposed rule on Medicare Coverage of Innovative Technology and definition of ‘reasonable and necessary’ Research Areas: Beneficiaries and Coverage, Drugs, Devices, and Tests, Medicare Spending and Financing
Oct 06, 2020 / Transcripts October 2020 meeting transcript Research Areas: Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality